Genomics In Cancer Care Global Market Report 2025

Description

Genomics in cancer care involves the comprehensive examination of all variations in DNA sequence and gene expression between tumor cells and healthy host cells. This approach aims to identify patients' genetic backgrounds for more effective cancer treatment. Genomics in cancer care is utilized to detect cancer-causing mutations, improve tumor-specific diagnostic techniques and treatment plans, facilitate precision medicine research and drug development, and enable the creation of targeted therapies to offer personalized treatment to patients with various types of cancers.

The main product types in genomics for cancer care include instruments, consumables, and services. Instruments are devices or equipment used for the detection of tumors in cancer genomics, providing accurate diagnostics. Various technologies, such as PCR, microarrays, genome sequencing, and others, are employed in these instruments. The applications of genomics in cancer care span diagnostics, personalized medicine, drug discovery and development, and research. These applications are utilized by hospitals, government institutes, and research facilities to enhance cancer diagnosis and treatment strategies.

The genomics in cancer care market research report is one of a series of new reports from The Business Research Company that provides genomics in cancer care market statistics, including genomics in cancer care industry global market size, regional shares, competitors with a genomics in cancer care market share, detailed genomics in cancer care market segments, market trends and opportunities, and any further data you may need to thrive in the genomics in cancer care industry. This genomics in cancer care market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The genomics in cancer care market size has grown rapidly in recent years. It will grow from $17.6 billion in 2024 to $20.73 billion in 2025 at a compound annual growth rate (CAGR) of 17.8%. The growth in the historic period can be attributed to early research and development, development of companion diagnostics, ethical and legal frameworks, data standardization and interpretation, initial market penetration.

The genomics in cancer care market size is expected to see rapid growth in the next few years. It will grow to $38.57 billion in 2029 at a compound annual growth rate (CAGR) of 16.8%. The growth in the forecast period can be attributed to increasing prevalence of cancer, advancements in data analytics, market expansion in emerging economies, genomic data privacy and security, improving healthcare infrastructure. Major trends in the forecast period include technological advancements, personalized medicine, reduced costs of genomic sequencing, regulatory support and guidelines, patient awareness and demand.

The increasing demand for cancer diagnostics is projected to boost the role of genomics in the cancer care market. Cancer diagnostics involves identifying the specific type, location, extent, and stage of tumors through various tests and procedures that confirm the presence of the disease. Genomics in cancer care aids in formulating appropriate treatment plans for patients by analyzing their genetic profiles. For instance, a report from Cancer Research UK, a UK-based cancer research organization, indicated in July 2024 that the average annual number of new cancer cases in the UK is anticipated to rise from approximately 420,000 cases between 2023 and 2025 to around 506,000 cases by 2038-2040. Therefore, the growing demand for cancer diagnostics is expected to drive the advancement of genomics in the cancer care market.

The genomics in cancer care market is experiencing growth, propelled by an increase in funding and investments for genomics research in cancer. Significant financial resources are being directed towards companies and initiatives advancing genomics technologies in cancer care. Investors are particularly interested in supporting innovative technologies, ranging from next-generation sequencing platforms to liquid biopsy assays, which provide comprehensive genomic profiling and non-invasive monitoring of cancer progression. Notably, the UK government's substantial investment of around £175 million to boost genomics research underscores the increasing financial support for cutting-edge genomic healthcare solutions. This influx of funding and investments is a key factor driving the growth of the genomics in cancer care market.

Leading companies in the genomics in cancer care market are prioritizing the introduction of robotic genomic testing facilities to improve the accuracy and efficiency of genetic testing, decrease turnaround times, and enhance patient outcomes through personalized treatment strategies tailored to individual genetic profiles. Robotic genomic testing facilities are advanced laboratory environments equipped with automated systems and robotic technologies designed to conduct various genomic analyses. For example, utilizing Automata's LINQ platform, the lab features six robotic arms that automate the preparation of samples from different biological materials, such as saliva, blood, bone marrow, and tissue biopsies. In September 2024, The Royal Marsden NHS Foundation Trust, a UK-based cancer hospital, launched a robotic genomic testing facility aimed at improving cancer diagnosis and treatment. This facility will double the genomic testing capacity of the Royal Marsden, enabling a higher volume of tests to be processed without sacrificing accuracy.

Major companies operating in the genomics in cancer care market are engaging in strategic partnerships to strengthen their positions. These partnerships involve structured affiliations between commercial enterprises, often established through business agreements or contracts. The collaboration between C2i Genomics and Karkinos Healthcare exemplifies this trend, where innovative cancer detection technology is brought together with the goal of driving research and development (R&D), establishing future pharma partnerships, and facilitating clinical use in India. Such strategic partnerships contribute to the expansion and global scalability of genomics in cancer care technologies, fostering growth and development in the market.

In December 2023, Pfizer Inc., a US-based company, completed the acquisition of Seagen Inc. for $43 billion. This acquisition is intended to enhance Pfizer's portfolio by integrating Seagen's expertise in delivering cancer care through innovative genomic approaches. Seagen Inc. specializes in providing cancer treatment using advanced genomic strategies.

Major companies operating in the genomics in cancer care market are Illumina Inc., Thermo Fisher Scientific Inc., Agilent Technologies Inc., PerkinElmer Inc., QIAGEN N.V., Bio-Rad Laboratories Inc., Danaher Corporation, Pacific Biosciences of California Inc., Roche Holding AG, Quest Diagnostics Incorporated, DiaSorin S.p.A., BGI Group, Myriad Genetics Inc., NeoGenomics Laboratories, Foundation Medicine Inc., Intermountain Healthcare, Laboratory Corporation of America Holdings, Flatiron Health Inc., Personal Genome Diagnostics Inc., Natera Inc., GRAIL Inc., Freenome Holdings Inc., Caris Life Sciences Inc., Tempus Labs Inc., OncoDNA S.A., Biocept Inc., GenomOncology Corp., OncoCyte Corporation, PathAI Inc., Enzyme Corporation, Karius Inc., N-of-One Inc., Oncora Medical Inc., Paradigm Diagnostics Inc., PierianDx Inc., Predicine Inc., Resolution Bioscience Inc., Strata Oncology Inc.

North America was the largest region in the genomics in cancer care market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the genomics in cancer care market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the genomics in cancer care market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The genomics in the cancer care market consists of revenues earned by entities by providing sequencing to identify DNA and RNA alterations, and defining molecular subtypes. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Genomics In Cancer Care Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on genomics in cancer care market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for genomics in cancer care ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The genomics in cancer care market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The market characteristics section of the report defines and explains the market.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered:1) By Product Type: Instruments; Consumables; Services
2) By Technology: PCR (Polymerase Chain Reaction); MicroArrays; Genome Sequencing; Other Technologies
3) By Application: Diagnostics; Personalized Medicine; Drug Discovery And Development; Research
4) By End-User: Hospitals; Government Institutes; Research Facilities
Subsegments:
1) By Instruments: Sequencers; PCR Machines; Microarrays; Other Diagnostic Instruments
2) By Consumables: Reagents And Kits; Sample Preparation Products; Nucleotides; Other Consumables
3) By Services: Data Analysis Services; Bioinformatics Services; Genetic Testing Services; Other Support Services
Companies Mentioned: Illumina Inc.; Thermo Fisher Scientific Inc.; Agilent Technologies Inc.; PerkinElmer Inc.; QIAGEN N.V.
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery format: PDF, Word and Excel Data Dashboard.

Product Code: r22642

1. Executive Summary

2. Genomics In Cancer Care Market Characteristics

3. Genomics In Cancer Care Market Trends And Strategies

4. Genomics In Cancer Care Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics And Covid And Recovery On The Market

5. Global Genomics In Cancer Care Growth Analysis And Strategic Analysis Framework

5.1. Global Genomics In Cancer Care PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
5.2. Analysis Of End Use Industries
5.3. Global Genomics In Cancer Care Market Growth Rate Analysis
5.4. Global Genomics In Cancer Care Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
5.5. Global Genomics In Cancer Care Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
5.6. Global Genomics In Cancer Care Total Addressable Market (TAM)

6. Genomics In Cancer Care Market Segmentation

6.1. Global Genomics In Cancer Care Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Instruments
Consumables
Services
6.2. Global Genomics In Cancer Care Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
PCR (Polymerase Chain Reaction)
MicroArrays
Genome Sequencing
Other Technologies
6.3. Global Genomics In Cancer Care Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Diagnostics
Personalized Medicine
Drug Discovery And Development
Research
6.4. Global Genomics In Cancer Care Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Hospitals
Government Institutes
Research Facilities
6.5. Global Genomics In Cancer Care Market, Sub-Segmentation Of Instruments, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Sequencers
PCR Machines
Microarrays
Other Diagnostic Instruments
6.6. Global Genomics In Cancer Care Market, Sub-Segmentation Of Consumables, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Reagents And Kits
Sample Preparation Products
Nucleotides
Other Consumables
6.7. Global Genomics In Cancer Care Market, Sub-Segmentation Of Services, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Data Analysis Services
Bioinformatics Services
Genetic Testing Services
Other Support Services

7. Genomics In Cancer Care Market Regional And Country Analysis

7.1. Global Genomics In Cancer Care Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
7.2. Global Genomics In Cancer Care Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Genomics In Cancer Care Market

8.1. Asia-Pacific Genomics In Cancer Care Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Genomics In Cancer Care Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.3. Asia-Pacific Genomics In Cancer Care Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.4. Asia-Pacific Genomics In Cancer Care Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Genomics In Cancer Care Market

9.1. China Genomics In Cancer Care Market Overview
9.2. China Genomics In Cancer Care Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.3. China Genomics In Cancer Care Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.4. China Genomics In Cancer Care Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Genomics In Cancer Care Market

10.1. India Genomics In Cancer Care Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.2. India Genomics In Cancer Care Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.3. India Genomics In Cancer Care Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Genomics In Cancer Care Market

11.1. Japan Genomics In Cancer Care Market Overview
11.2. Japan Genomics In Cancer Care Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.3. Japan Genomics In Cancer Care Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.4. Japan Genomics In Cancer Care Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Genomics In Cancer Care Market

12.1. Australia Genomics In Cancer Care Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.2. Australia Genomics In Cancer Care Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.3. Australia Genomics In Cancer Care Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Genomics In Cancer Care Market

13.1. Indonesia Genomics In Cancer Care Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.2. Indonesia Genomics In Cancer Care Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.3. Indonesia Genomics In Cancer Care Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Genomics In Cancer Care Market

14.1. South Korea Genomics In Cancer Care Market Overview
14.2. South Korea Genomics In Cancer Care Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.3. South Korea Genomics In Cancer Care Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.4. South Korea Genomics In Cancer Care Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Genomics In Cancer Care Market

15.1. Western Europe Genomics In Cancer Care Market Overview
15.2. Western Europe Genomics In Cancer Care Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.3. Western Europe Genomics In Cancer Care Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.4. Western Europe Genomics In Cancer Care Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Genomics In Cancer Care Market

16.1. UK Genomics In Cancer Care Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.2. UK Genomics In Cancer Care Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.3. UK Genomics In Cancer Care Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Genomics In Cancer Care Market

17.1. Germany Genomics In Cancer Care Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.2. Germany Genomics In Cancer Care Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.3. Germany Genomics In Cancer Care Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Genomics In Cancer Care Market

18.1. France Genomics In Cancer Care Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.2. France Genomics In Cancer Care Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.3. France Genomics In Cancer Care Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Genomics In Cancer Care Market

19.1. Italy Genomics In Cancer Care Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.2. Italy Genomics In Cancer Care Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.3. Italy Genomics In Cancer Care Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Genomics In Cancer Care Market

20.1. Spain Genomics In Cancer Care Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.2. Spain Genomics In Cancer Care Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.3. Spain Genomics In Cancer Care Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Genomics In Cancer Care Market

21.1. Eastern Europe Genomics In Cancer Care Market Overview
21.2. Eastern Europe Genomics In Cancer Care Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.3. Eastern Europe Genomics In Cancer Care Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.4. Eastern Europe Genomics In Cancer Care Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Genomics In Cancer Care Market

22.1. Russia Genomics In Cancer Care Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.2. Russia Genomics In Cancer Care Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.3. Russia Genomics In Cancer Care Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Genomics In Cancer Care Market

23.1. North America Genomics In Cancer Care Market Overview
23.2. North America Genomics In Cancer Care Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.3. North America Genomics In Cancer Care Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.4. North America Genomics In Cancer Care Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Genomics In Cancer Care Market

24.1. USA Genomics In Cancer Care Market Overview
24.2. USA Genomics In Cancer Care Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.3. USA Genomics In Cancer Care Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.4. USA Genomics In Cancer Care Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Genomics In Cancer Care Market

25.1. Canada Genomics In Cancer Care Market Overview
25.2. Canada Genomics In Cancer Care Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.3. Canada Genomics In Cancer Care Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.4. Canada Genomics In Cancer Care Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Genomics In Cancer Care Market

26.1. South America Genomics In Cancer Care Market Overview
26.2. South America Genomics In Cancer Care Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.3. South America Genomics In Cancer Care Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.4. South America Genomics In Cancer Care Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Genomics In Cancer Care Market

27.1. Brazil Genomics In Cancer Care Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.2. Brazil Genomics In Cancer Care Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.3. Brazil Genomics In Cancer Care Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Genomics In Cancer Care Market

28.1. Middle East Genomics In Cancer Care Market Overview
28.2. Middle East Genomics In Cancer Care Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.3. Middle East Genomics In Cancer Care Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.4. Middle East Genomics In Cancer Care Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Genomics In Cancer Care Market

29.1. Africa Genomics In Cancer Care Market Overview
29.2. Africa Genomics In Cancer Care Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.3. Africa Genomics In Cancer Care Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.4. Africa Genomics In Cancer Care Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Genomics In Cancer Care Market Competitive Landscape And Company Profiles

30.1. Genomics In Cancer Care Market Competitive Landscape
30.2. Genomics In Cancer Care Market Company Profiles
- 30.2.1. Illumina Inc. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.2. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.3. Agilent Technologies Inc. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.4. PerkinElmer Inc. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.5. QIAGEN N.V. Overview, Products and Services, Strategy and Financial Analysis

31. Genomics In Cancer Care Market Other Major And Innovative Companies

31.1. Bio-Rad Laboratories Inc.
31.2. Danaher Corporation
31.3. Pacific Biosciences of California Inc.
31.4. Roche Holding AG
31.5. Quest Diagnostics Incorporated
31.6. DiaSorin S.p.A.
31.7. BGI Group
31.8. Myriad Genetics Inc.
31.9. NeoGenomics Laboratories
31.10. Foundation Medicine Inc.
31.11. Intermountain Healthcare
31.12. Laboratory Corporation of America Holdings
31.13. Flatiron Health Inc.
31.14. Personal Genome Diagnostics Inc.
31.15. Natera Inc.

32. Global Genomics In Cancer Care Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Genomics In Cancer Care Market

34. Recent Developments In The Genomics In Cancer Care Market

35. Genomics In Cancer Care Market High Potential Countries, Segments and Strategies

35.1 Genomics In Cancer Care Market In 2029 - Countries Offering Most New Opportunities
35.2 Genomics In Cancer Care Market In 2029 - Segments Offering Most New Opportunities
35.3 Genomics In Cancer Care Market In 2029 - Growth Strategies
- 35.3.1 Market Trend Based Strategies
- 35.3.2 Competitor Strategies

36. Appendix

36.1. Abbreviations
36.2. Currencies
36.3. Historic And Forecast Inflation Rates
36.4. Research Inquiries
36.5. The Business Research Company
36.6. Copyright And Disclaimer